After court ruling, Governor Healey announces actions taken to keep medication abortion in Massachusetts

BOSTON – Following a federal court ruling in Texas in the case of Alliance for Hippocratic Medicine v. U.S. Food & Drug Administration that blocked the FDA’s approval of the abortion medication mifepristone, Massachusetts Governor Maura Healey announced steps that the state is taking. At the Governor’s request, the University of Massachusetts and health care providers have taken action to stockpile doses of mifepristone, and the Governor is issuing an Executive Order confirming protections for medication abortion under existing state law.

“Medication abortion is safe, effective and legal. Mifepristone has been used safely for more than 20 years and is the gold standard. Here in Massachusetts, we are not going to let one extremist judge in Texas turn back the clock on this proven medication and restrict access to care in our state,” said Governor Healey. “The action we are taking today protects access to mifepristone in Massachusetts and protects patients and providers from liability. In Massachusetts, we stand for civil rights and freedom. We will always protect access to reproductive health care, including medication abortion.”

“Our administration is grateful for the partnership of UMass and health care providers across the state who readily agreed to take this urgent action to protect access to care,” said Lieutenant Governor Kimberley Driscoll. “We’re also grateful for the hard work of legislators, advocates and the public health community who rallied to pass protections after the Dobbs decision last year. These efforts ensured we had the option to take this meaningful action to protect access to medication abortion.”

At Governor Healey’s request, the University of Massachusetts Amherst last week purchased approximately 15,000 doses of mifepristone to ensure sufficient coverage in the state for more than a year. The doses are expected to arrive this week. Health care providers in Massachusetts have also agreed to purchase additional quantities to make available for patients. The Healey-Driscoll Administration is also dedicating $1 million to support providers contracted with Department of Public Health with paying for these doses.

“We are pleased to answer the Governor’s call to provide this vital assistance to the Commonwealth,” said Marty Meehan, President of Umass and Kumble Subbaswamy, Chancellor of Umass Amherst. “Helping to ensure access to safe, effective, reproductive healthcare for the residents of Massachusetts is fully aligned with UMass Amherst’s longstanding mission to serve the Commonwealth.”

Additionally, Governor Healey is issuing an Executive Order confirming that the 2022 Shield Law should be interpreted as protecting access to medication abortion, including mifepristone. This will ensure that providers, including pharmacists, can continue to stock and dispense mifepristone and will protect providers and patients from criminal and civil liability. The Executive Order also instructs the Department of Public Health and Division of Insurance to issue guidance to help implement the order and requires the Department of Public Health to provide support to public universities and colleges to expedite development and implementation of their medication abortion readiness plans.

In addition to abortion care, mifepristone is also used for miscarriage management, to treat lupus, and to reduce the risk of ulcers, among many other medical uses.